OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 70 filers reported holding OPHTHOTECH CORP in Q1 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $44,000 | -12.0% | 16,110 | 0.0% | 0.08% | +8.0% |
| Q4 2017 | $50,000 | +11.1% | 16,110 | 0.0% | 0.08% | -20.2% |
| Q3 2017 | $45,000 | -93.9% | 16,110 | 0.0% | 0.09% | -95.6% |
| Q3 2016 | $743,000 | -9.6% | 16,110 | 0.0% | 2.12% | -23.3% |
| Q2 2016 | $822,000 | +20.7% | 16,110 | 0.0% | 2.76% | +17.3% |
| Q1 2016 | $681,000 | -46.2% | 16,110 | 0.0% | 2.36% | -39.9% |
| Q4 2015 | $1,265,000 | +93.7% | 16,110 | 0.0% | 3.92% | +91.5% |
| Q3 2015 | $653,000 | -22.2% | 16,110 | 0.0% | 2.05% | -13.1% |
| Q2 2015 | $839,000 | +11.9% | 16,110 | 0.0% | 2.36% | +211.6% |
| Q1 2015 | $750,000 | -48.1% | 16,110 | -50.0% | 0.76% | -47.4% |
| Q4 2014 | $1,446,000 | +15.3% | 32,220 | 0.0% | 1.44% | +102.5% |
| Q3 2014 | $1,254,000 | -8.0% | 32,220 | 0.0% | 0.71% | -3.5% |
| Q2 2014 | $1,363,000 | – | 32,220 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |